An Ashkenazi Jewish SMN1 Haplotype Specific to Duplication Alleles Improves Pan-Ethnic Carrier Screening for Spinal Muscular Atrophy

Genetics in Medicine - United States
doi 10.1038/gim.2013.84
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Carrier Screening for Spinal Muscular Atrophy

Genetics in Medicine
MedicineGenetics
2008English

Spinal Muscular Atrophy Diagnosis and Carrier Screening From Genome Sequencing Data

Genetics in Medicine
MedicineGenetics
2020English

Non-Invasive Prenatal Diagnosis of Spinal Muscular Atrophy by Relative Haplotype Dosage

European Journal of Human Genetics
Genetics
2017English

Lessons Learned From Expanded Reproductive Carrier Screening in Self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish Patients

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Novel Therapeutic Strategies for Spinal Muscular Atrophy

Future Neurology
Neurology
2015English

Spinal Muscular Atrophy Type 1

Pediatric Critical Care Medicine
Child HealthCritical CarePediatricsPerinatologyIntensive Care Medicine
2012English

ML372 Blocks SMN Ubiquitination and Improves Spinal Muscular Atrophy Pathology in Mice

JCI insight
Medicine
2016English

Funding for Spinal Muscular Atrophy Research Must Continue

Future Neurology
Neurology
2019English

Autonomic Dysfunction in Spinal Muscular Atrophy

Turkiye Klinikleri Pediatri
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy